Literature DB >> 24035680

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine.

Carolyn D Hurst1, Fiona M Platt1, Margaret A Knowles2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24035680     DOI： 10.1016/j.eururo.2013.08.057

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  61 in total

1.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

2.  Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.

Authors:  Dong-Sheng Huang; Zhaohui Wang; Xu-Jun He; Bill H Diplas; Rui Yang; Patrick J Killela; Qun Meng; Zai-Yuan Ye; Wei Wang; Xiao-Ting Jiang; Li Xu; Xiang-Lei He; Zhong-Sheng Zhao; Wen-Juan Xu; Hui-Ju Wang; Ying-Yu Ma; Ying-Jie Xia; Li Li; Ru-Xuan Zhang; Tao Jin; Zhong-Kuo Zhao; Ji Xu; Sheng Yu; Fang Wu; Junbo Liang; Sizhen Wang; Yuchen Jiao; Hai Yan; Hou-Quan Tao
Journal:  Eur J Cancer       Date:  2015-04-02       Impact factor: 9.162

3.  Frequency of TERT promoter mutations in primary tumors of the liver.

Authors:  Alexander Quaas; Theresa Oldopp; Lars Tharun; Catina Klingenfeld; Till Krech; Guido Sauter; Tobias J Grob
Journal:  Virchows Arch       Date:  2014-09-30       Impact factor: 4.064

Review 4.  Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.

Authors:  Aadel A Chaudhuri; Bruna Pellini; Nadja Pejovic; Pradeep S Chauhan; Peter K Harris; Jeffrey J Szymanski; Zachary L Smith; Vivek K Arora
Journal:  JCO Precis Oncol       Date:  2020-07-15

Review 5.  Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.

Authors:  Woonyoung Choi; Andrea Ochoa; David J McConkey; Mattias Aine; Mattias Höglund; William Y Kim; Francisco X Real; Anne E Kiltie; Ian Milsom; Lars Dyrskjøt; Seth P Lerner
Journal:  Eur Urol       Date:  2017-03-30       Impact factor: 20.096

6.  Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.

Authors:  Morgan L Cowan; Simeon Springer; Doreen Nguyen; Diana Taheri; Gunes Guner; Maria Angelica Mendoza Rodriguez; Yuxuan Wang; Isaac Kinde; Maria Del Carmen Rodriguez Pena; Christopher J VandenBussche; Mathew T Olson; Isabela Cunha; Kazutoshi Fujita; Dilek Ertoy; Kenneth Kinzler; Trinity Bivalacqua; Nickolas Papadopoulos; Bert Vogelstein; George J Netto
Journal:  Hum Pathol       Date:  2016-03-10       Impact factor: 3.466

Review 7.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

8.  Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.

Authors:  Nils J Fredriksson; Lars Ny; Jonas A Nilsson; Erik Larsson
Journal:  Nat Genet       Date:  2014-11-10       Impact factor: 38.330

Review 9.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Authors:  Margaret A Knowles; Carolyn D Hurst
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

Review 10.  Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.

Authors:  Richard T Bryan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.